Diagnostic impact of the 2016 revised who criteria for polycythemia vera

被引：28
作者：
Barbui, Tiziano [1 ]
Thiele, Juergen [2 ]
Gisslinger, Heinz [3 ]
Carobbio, Alessandra [1 ]
Vannucchi, Alessandro M. [4 ]
Tefferi, Ayalew [5 ]
机构：
[1] Papa Giovanni XXIII Hosp, FROM Res Fdn, Bergamo, Italy
[2] Univ Cologne, Inst Pathol, Cologne, Germany
[3] Med Univ Vienna, Hematol Div, Vienna, Austria
[4] Univ Florence, Dept Expt & Clin Med, Florence, Italy
[5] Mayo Clin, Hematol Div, Rochester, MN USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2017年 / 92卷 / 05期
关键词：
ESSENTIAL THROMBOCYTHEMIA; MYELOPROLIFERATIVE NEOPLASMS; RISK-STRATIFICATION; JAK2;
D O I：
10.1002/ajh.24684
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：417 / 419
页数：3
相关论文
共 10 条
[1]   The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J].
Arber, Daniel A. ;
Orazi, Attilio ;
Hasserjian, Robert ;
Thiele, Jurgen ;
Borowitz, Michael J. ;
Le Beau, Michelle M. ;
Bloomfield, Clara D. ;
Cazzola, Mario ;
Vardiman, James W. .
BLOOD, 2016, 127 (20) :2391-2405
[2]   The rate of transformation from JAK2-mutated ET to PV is influenced by an accurate WHO-defined clinico-morphological diagnosis [J].
Barbui, T. ;
Thiele, J. ;
Carobbio, A. ;
Vannucchi, A. M. ;
Tefferi, A. .
LEUKEMIA, 2015, 29 (04) :992-993
[3]   Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients [J].
Barbui, Tiziano ;
Thiele, Juergen ;
Carobbio, Alessandra ;
Guglielmelli, Paola ;
Rambaldi, Alessandro ;
Vannucchi, Alessandro M. ;
Tefferi, Ayalew .
AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) :588-590
[4]   Masked polycythemia Vera (mPV): Results of an international study [J].
Barbui, Tiziano ;
Thiele, Juergen ;
Gisslinger, Heinz ;
Finazzi, Guido ;
Carobbio, Alessandra ;
Rumi, Elisa ;
Randi, Maria Luigia ;
Betozzi, Irene ;
Vannucchi, Alessandro M. ;
Pieri, Lisa ;
Carrai, Valentina ;
Gisslinger, Bettina ;
Muellauer, Leonhard ;
Ruggeri, Marco ;
Rambaldi, Alessandro ;
Tefferi, Ayalew .
AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (01) :52-54
[5]  
Busque L, 2016, AM J CLIN PATHOL, V146, P408, DOI [10.1093/AJCP/AQW131, 10.1093/ajcp/aqw131]
[6]  
Ethier V, 2016, BLOOD
[7]   A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera [J].
Lussana, Federico ;
Carobbio, Alessandra ;
Randi, Maria L. ;
Elena, Chiara ;
Rumi, Elisa ;
Finazzi, Guido ;
Bertozzi, Irene ;
Pieri, Lisa ;
Ruggeri, Marco ;
Palandri, Francesca ;
Polverelli, Nicola ;
Elli, Elena ;
Tieghi, Alessia ;
Iurlo, Alessandra ;
Ruella, Marco ;
Cazzola, Mario ;
Rambaldi, Alessandro ;
Vannucchi, Alessandro M. ;
Barbui, Tiziano .
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (04) :541-546
[8]   Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms [J].
Rumi, Elisa ;
Cazzola, Mario .
BLOOD, 2017, 129 (06) :680-692
[9]   JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes [J].
Rumi, Elisa ;
Pietra, Daniela ;
Ferretti, Virginia ;
Klampfl, Thorsten ;
Harutyunyan, Ashot S. ;
Milosevic, Jelena D. ;
Them, Nicole C. C. ;
Berg, Tiina ;
Elena, Chiara ;
Casetti, Ilaria C. ;
Milanesi, Chiara ;
Sant'Antonio, Emanuela ;
Bellini, Marta ;
Fugazza, Elena ;
Renna, Maria C. ;
Boveri, Emanuela ;
Astori, Cesare ;
Pascutto, Cristiana ;
Kralovics, Robert ;
Cazzola, Mario .
BLOOD, 2014, 123 (10) :1544-1551
[10]   Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management [J].
Tefferi, Ayalew ;
Barbui, Tiziano .
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (01) :95-108
1